Cost-Effectiveness of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: Modeled Lifetime Analysis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the cost-effectiveness of surgically induced weight loss relative to conventional therapy for the management of recently diagnosed type 2 diabetes in class I/II obese patients. RESEARCH DESIGN AND METHODS: This study builds on a within-trial cost-efficacy analysis. The analysis compares the lifetime costs and quality-adjusted life-years (QALYs) between the two intervention groups. Intervention costs were extrapolated based on observed resource utilization during the trial. The proportion of patients in each intervention group with remission of diabetes at 2 years was the same as that observed in the trial. Health care costs for patients with type 2 diabetes and outcome variables required to derive estimates of QALYs were sourced from published literature. A health care system perspective was adopted. Costs and outcomes were discounted annually at 3%. Costs are presented in 2006 Australian dollars (AUD) (currency exchange: 1 AUD = 0.74 USD). RESULTS: The mean number of years in diabetes remission over a lifetime was 11.4 for surgical therapy patients and 2.1 for conventional therapy patients. Over the remainder of their lifetime, surgical and conventional therapy patients lived 15.7 and 14.5 discounted QALYs, respectively. The mean discounted lifetime costs were 98,900 AUD per surgical therapy patient and 101,400 AUD per conventional therapy patient. Relative to conventional therapy, surgically induced weight loss was associated with a mean health care saving of 2,400 AUD and 1.2 additional QALYs per patient. CONCLUSIONS: Surgically induced weight loss is a dominant intervention (it both saves health care costs and generates health benefits) for managing recently diagnosed type 2 diabetes in class I/II obese patients in Australia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572 · cited 1×
“The analysis did not seek to capture non–diabetes-related 1) health care cost savings associated with a reduction in obesity-related morbidity (19), 2) improvements in quality of life attributable to weight loss after bariatric surgery (20), or 3) survival benefits of weight loss after bariatric surgery (19,21).”
BackgroundPories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00011 · Cited by 2,293 · cited 1×
“The Swedish Obese Study (SOS) and the Greenville Series report that, for patients achieving diabetes remission after surgically induced weight loss, the mean duration of remission is 10 years and substantially greater than 16 years, respectively (3,5).”
BackgroundDixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Self-citationEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
Christou, N. V., Sampalis, J. S., Liberman, M., Look, D., Auger, S., McLean, A. P. H., & MacLean, L. D. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000137343.63376.19 · Cited by 1,288
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Bowman, B., Serdula, M., Brown, T. J., Schmid, C. H., & Lau, J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.024 · Cited by 253
Cited by
Bariatric surgery: an IDF statement for obese Type 2 diabetes
Dixon, J. B., Zimmet, P., Alberti, K. G., Rubino, F., & on behalf of the International Diabetes Federation Taskforce on Epidemiology and Prevention (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03306.x · Cited by 494
Self-citationLaparoscopic Adjustable Gastric Banding in Severely Obese Adolescents: A Randomized Trial
O’Brien, P. E., Sawyer, S. M., Laurie, C., Brown, W. A., Skinner, S., Veit, F., Paul, E., Burton, P. R., McGrice, M., Anderson, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.81 · Cited by 367
Self-citationMartin, M., Beekley, A., Kjorstad, R., & Sebesta, J. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.07.003 · Cited by 338
Changes in Utilization of Bariatric Surgery in the United States From 1993 to 2016
Campos, G. M., Khoraki, J., Browning, M. G., Pessoa, B. M., Mazzini, G. S., & Wolfe, L. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003554 · Cited by 326
Dixon, J. B., Schachter, L. M., O’Brien, P. E., Jones, K., Grima, M., Lambert, G., Brown, W., Bailey, M., & Naughton, M. T. (2012) · JAMA · doi:10.1001/2012.jama.11580 · Cited by 310
Self-citation
Metadata
- Authors
- Keating, C. L., Dixon, J. B., Moodie, M. L., Peeters, A., Bulfone, L., Maglianno, D. J., & O'Brien, P. E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-01-26
- Volume
- 32
- Issue
- 4
- Pages
- 567-574
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2133544307
- Cited by
- 146
- References
- 7
- FWCI
- 16.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.